Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | ONCOLOGY//CELL BIOLOGY//BIOCHEMISTRY & MOLECULAR BIOLOGY | 2934640 |
361 | 3 | ADENOVIRUS//MERKEL CELL CARCINOMA//POLYOMAVIRUS | 35836 |
818 | 2 | ONCOLYTIC VIRUS//GENE THERAPY//HUMAN GENE THERAPY | 12130 |
1202 | 2 | MERKEL CELL CARCINOMA//POLYOMAVIRUS//JC VIRUS | 9520 |
1472 | 2 | ADENOVIRUS//VIROLOGY//E1A | 7957 |
1914 | 2 | MARINER//SLEEPING BEAUTY//TRANSGENE | 6229 |
Terms with highest relevance score |
rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|---|
1 | ADENOVIRUS | authKW | 593741 | 5% | 36% | 1867 |
2 | MERKEL CELL CARCINOMA | authKW | 466882 | 2% | 87% | 613 |
3 | POLYOMAVIRUS | authKW | 386055 | 2% | 78% | 563 |
4 | GENE THERAPY | authKW | 360819 | 7% | 17% | 2473 |
5 | JC VIRUS | authKW | 341057 | 1% | 91% | 427 |
6 | PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY | authKW | 328686 | 1% | 83% | 454 |
7 | BK VIRUS | authKW | 324263 | 1% | 90% | 411 |
8 | HUMAN GENE THERAPY | journal | 265465 | 3% | 30% | 1013 |
9 | ONCOLYTIC VIRUS | authKW | 250880 | 1% | 75% | 382 |
10 | VIROLOGY | WoSSC | 184654 | 17% | 4% | 6265 |
Web of Science journal categories |
chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | Virology | 184654 | 17% | 4% | 6265 |
2 | Genetics & Heredity | 58003 | 18% | 1% | 6331 |
3 | Biotechnology & Applied Microbiology | 55009 | 18% | 1% | 6314 |
4 | Medicine, Research & Experimental | 53264 | 15% | 1% | 5498 |
5 | Biochemistry & Molecular Biology | 17880 | 22% | 0% | 7879 |
6 | Oncology | 17394 | 13% | 1% | 4770 |
7 | Cell Biology | 13622 | 12% | 1% | 4225 |
8 | Transplantation | 3531 | 2% | 1% | 876 |
9 | Hematology | 2733 | 3% | 0% | 1245 |
10 | Developmental Biology | 2587 | 2% | 1% | 743 |
Address terms |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | HUMAN GENE THER Y | 110941 | 1% | 43% | 293 |
2 | CANC GENE THER Y GRP | 61946 | 0% | 67% | 105 |
3 | GENE THER Y | 50441 | 1% | 15% | 401 |
4 | GENE TRANSFER REGULAT | 28831 | 0% | 66% | 50 |
5 | SAN DIEGO SCI | 27459 | 0% | 61% | 51 |
6 | MOL MED NEUROSCI | 25603 | 0% | 46% | 64 |
7 | EXPT HEMATOL | 23736 | 1% | 13% | 216 |
8 | MOL MED GENE THER Y UNIT | 23351 | 0% | 76% | 35 |
9 | GENE THER Y PROGRAM | 20842 | 0% | 21% | 115 |
10 | NEUROTOXICOL SECT | 18044 | 0% | 86% | 24 |
Journals |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | HUMAN GENE THERAPY | 265465 | 3% | 30% | 1013 |
2 | GENE THERAPY | 201482 | 3% | 24% | 956 |
3 | MOLECULAR THERAPY | 160675 | 2% | 22% | 823 |
4 | CANCER GENE THERAPY | 155581 | 2% | 30% | 590 |
5 | JOURNAL OF VIROLOGY | 134649 | 7% | 6% | 2505 |
6 | JOURNAL OF GENE MEDICINE | 57862 | 1% | 22% | 309 |
7 | VIROLOGY | 56220 | 3% | 6% | 1111 |
8 | TRANSGENIC RESEARCH | 31108 | 1% | 15% | 247 |
9 | CURRENT GENE THERAPY | 25545 | 0% | 23% | 130 |
10 | MOLECULAR THERAPY-ONCOLYTICS | 18067 | 0% | 54% | 38 |
Author Key Words |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass | LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | ADENOVIRUS | 593741 | 5% | 36% | 1867 | Search ADENOVIRUS | Search ADENOVIRUS |
2 | MERKEL CELL CARCINOMA | 466882 | 2% | 87% | 613 | Search MERKEL+CELL+CARCINOMA | Search MERKEL+CELL+CARCINOMA |
3 | POLYOMAVIRUS | 386055 | 2% | 78% | 563 | Search POLYOMAVIRUS | Search POLYOMAVIRUS |
4 | GENE THERAPY | 360819 | 7% | 17% | 2473 | Search GENE+THERAPY | Search GENE+THERAPY |
5 | JC VIRUS | 341057 | 1% | 91% | 427 | Search JC+VIRUS | Search JC+VIRUS |
6 | PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY | 328686 | 1% | 83% | 454 | Search PROGRESSIVE+MULTIFOCAL+LEUKOENCEPHALOPATHY | Search PROGRESSIVE+MULTIFOCAL+LEUKOENCEPHALOPATHY |
7 | BK VIRUS | 324263 | 1% | 90% | 411 | Search BK+VIRUS | Search BK+VIRUS |
8 | ONCOLYTIC VIRUS | 250880 | 1% | 75% | 382 | Search ONCOLYTIC+VIRUS | Search ONCOLYTIC+VIRUS |
9 | NATALIZUMAB | 161557 | 1% | 56% | 331 | Search NATALIZUMAB | Search NATALIZUMAB |
10 | ONCOLYTIC ADENOVIRUS | 121399 | 1% | 72% | 193 | Search ONCOLYTIC+ADENOVIRUS | Search ONCOLYTIC+ADENOVIRUS |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 3 |